---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-005950"
form_type: "8-K"
ticker: "CBIH"
cik: "0001411057"
company_name: "Cannabis Bioscience International Holdings, Inc."
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:02:46.121232+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cannabis Bioscience appoints John Jones director/treasurer; awards 125M shares annually; adopts clawback policy

## Summary
- John Jones appointed director and treasurer; agrees to make $37,500 payment under Diagonal SPA by Sept 15, 2024.
- Jones and Kamienski reduce note interest to 2.5% monthly, monthly payment to $5,000 on $291,451 principal note.
- Jones to receive 125M shares of common stock annually on each May 31 from 2025-2028 if serving as treasurer.
- Jose Torres receives 125M shares for 2024 secretary services, with similar amounts in 2025-2027.
- Vita Biotech to pay Alpha $50,000/month for 4-month term for clinical trials; Series B Preferred shares increased to 2,000.

## SEC filing metadata
- accession: 0001683168-24-005950
- form_type: 8-K
- ticker: CBIH
- cik: 0001411057
- company_name: Cannabis Bioscience International Holdings, Inc.
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411057/000168316824005950/0001683168-24-005950-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411057/000168316824005950/cannabisbio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-005950
- JSON: https://secwatch.observer/filing/0001683168-24-005950.json
- Plain text: https://secwatch.observer/filing/0001683168-24-005950.txt

## Key facts
- Executive change
  John Jones was appointed as Director and Treasurer at Cannabis Bioscience International Holdings, Inc..
  - Action: appointed
  - Role: Director and Treasurer
  source text: On August 20, 2024, pursuant to the Jones Agreement, Jones was appointed as a director by the board of directors, acting pursuant to the Registrant’s by-laws, to fill the vacancy in the board of directors created by the death of Henry Levinski on December 29, 2023, and as treasurer of the Registrant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411057/000168316824005950/0001683168-24-005950-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.